This clinical trial is focused on children who have experienced their first episode of severe wheezing, which is a type of breathing difficulty often associated with a viral infection called rhinovirus. The study aims to explore whether a treatment using a type of medication known as systemic corticosteroids can help prevent future episodes of wheezing and the development of asthma. The specific medication being tested is called dexamethasone, and it will be compared to a placebo, which looks like the medication but does not contain the active ingredient.

The purpose of the study is to determine if these corticosteroids can effectively reduce the risk of recurrent wheezing and asthma in young children. Participants in the study will receive either the dexamethasone treatment or a placebo. The study will monitor the children over a period of time to see how many experience new episodes of wheezing or develop asthma, which is a condition that causes the airways to become inflamed and narrow, making it difficult to breathe.

Throughout the study, researchers will also observe other factors such as the duration and severity of any breathing difficulties, the children’s overall quality of life, and their growth in terms of height and weight. This information will help determine the effectiveness of the treatment in preventing asthma and improving the health outcomes for children who have had a severe wheezing episode due to rhinovirus.